Guo S, Miao M, Wu Y, Pan D, et al. DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer. Oncogene 2024 Mar 13. doi: 10.1038/s41388-024-03005.
PMID: 38480915